News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat
Tuesday, December 03, 2024Oryzon Genomics SA ISIN Code ES ORY a clinicalstage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need announced today that the Russian Patent Office has issued a Decision to grant communi...
Polyrizon Enters into GMP Manufacturing Agreement for CTM Supply of its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial
Tuesday, December 03, 2024Polyrizon Ltd a development stage biotech company specializing in the development of innovative intranasal hydrogels announces today the signing of a manufacturing agreement with Eurofins CDMO Amatsiaquitaine SAS a leading Europeanbased Good Manufact...
QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis
Thursday, November 28, 2024QIAGEN announced the launch of two new tools for designing and ordering custom solutions that can be used to support microbial analysis of bacterial fungal and viral targets These new tools enable researchers to customize their assays and panels for...
Lin BioScience Receives U.S. FDA Fast Track Designation For LBS-007
Thursday, November 28, 2024Lin BioScience a clinicalstage biopharmaceutical drug development company focused on advancing novel therapeutics targeting acute leukemia that have significant unmet medical needs today announced that its lead pipeline LBS has been granted Fast Trac...
Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies
Wednesday, November 27, 2024Roche announced that it has entered into a definitive merger agreement to acquire Poseida Therapeutics Inc a public clinicalstage biopharmaceutical company pioneering donorderived CART cell therapies Based in San Diego California Poseidas RD portfoli...
Renexxion Ireland Ltd. Announces Issuance of Fifth New U.S. Patent Covering Novel Crystal Isoform of Naronapride
Wednesday, November 27, 2024Renexxion Ireland Limited a private biopharmaceutical company dedicated to delivering innovative treatments for patients with significant unmet needs in gastrointestinal GI disorders is pleased to announce a major milestone in its intellectual proper...
Pluri Evaluates Readiness for Mass Production of PLX-R18 for Acute Radiation Syndrome Amid Rising Nuclear Threat Concerns
Tuesday, November 26, 2024Pluri Inc a biotechnology company leveraging its proprietary platform for cellbased solutions to create a collaborative network of ventures today announced that it is assessing its readiness to initiate mass production of PLXR a novel potential treat...
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)
Tuesday, November 26, 2024Eton Pharmaceuticals Inc an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases today announced that it has acquired the US rights to Amglidia glyburide oral suspension known as glibenclamide in Eu...
SCG Cell Therapy Presents Promising Phase 1 Data for a Novel HBV-Specific TCR-T Therapy (SCG101) at the AASLD Liver Meeting 2024
Monday, November 25, 2024SCG Cell Therapy Pte Ltd SCG a clinicalstage biotechnology company focused on developing innovative immunotherapies for infectious diseases and associated cancers announced latebreaking data from its Phase trial of SCG a firstinclass autologous hepa...
Acies Bio and Protein Evolution Announce Strategic Partnership to Advance Biological Recycling Technology
Friday, November 22, 2024Protein Evolution a pioneer in enzymedriven plastics recycling has announced a collaboration with Acies Bio an innovative biotechnology company specializing in microbial RD and biomanufacturing This partnership aims to leverage Acies Bios stateofthea...
